https://www.selleckchem.com/pr....oducts/740-y-p-pdgfr
Purpose The numbers and types of oral oncolytics in oncology are expanding rapidly. Oral oncolytics have serious adverse effects, and pharmacist-driven patient education has the potential to reduce adverse events. The University of New Mexico Comprehensive Cancer Center (UNM CCC) initiated a patient education and consent process for oral oncolytics in our minority, rural, and economically disadvantaged population. Patients and methods The UNM CCC initiated a pharmacist-driven education and consent process from August 2016 t
Like
Comment
Share
